Categories: Budget

Prebudget Expectation Attributed to Mr. Gagan Singh Bedi, MD, AstraZeneca Pharma India Limited.

New Delhi, January 31, 2018: The single most important recommendation from industry remains that of increasing healthcare spend as share of GDP especially to address the high disease burden in the country. Impetus also needs to be provided to research & development to encourage innovation in India which currently stands at a meagre 0.69% of GDP. Effective implementation of the National Health Policy 2017 is needed for prevention and management of non-communicable diseases such as diabetes, asthma, heart diseases and cancer which is now becoming the leading cause of mortality in our country.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

18 hours ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

18 hours ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

2 days ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

2 days ago

Annual eye screening crucial for diabetic patients to protect eyesight: Dr Agarwals Eye Hospital

Dr Agarwals Eye Hospital, Bengaluru, is providing free consultations for diabetic patients aged 50 and…

4 days ago

7 Signs You Are Suffering From Protein Deficiency

By Ms. Archana S, Senior Nutritionist, Aster Whitefield Hospital, Bengaluru As an essential nutrient, protein…

4 days ago